Potential Value of Hormone Receptor Assay in Carcinoma In Situ of Breast
Authors:
Open Access
- 1 November 1990
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 94 (5) , 533-537
Abstract
The estrogen receptor (ER) expression of invasive breast cancer has been extensively studied both biochemically and with specific monoclonal antibodies against ER. Relatively few studies have attempted to characterize ER pattern in breast carcinoma in situ (CIS) and in other premalignant lesions. In the current study, the authors investigated the pattern of ER expression in 62 cases of breast CIS, 30 of which had a component of invasive cancer, and 36 cases of atypical hyperplasia. Paraffin sections of formalin- fixed breast tissue underwent enzyme pretreatment to expose nuclear antigenic sites as previously described. Breast tissues then underwent estrogen immunocytochemical assay using specific monoclonal antibodies (Abbott Laboratory, Chicago, IL). The cases were evaluated for heterogeneity, intensity of staining, and percentage of ER-positive cells. An attempt was made to study the relation between the pattern of ER expression, nuclear pleomorphism, and type of CIS. The results of ER immunocytochemical assay showed positive nuclear staining for ER in 75% of the CIS, 73% of CIS with invasive cancer, and 100% of atypical hyperplasias. ER expression in CIS agreed with that in the invasive carcinoma in 29 of 30 cases. This study also suggests that comedocarcinoma has a higher incidence of negative ER expression than the other types of CIS, particularly when it is associated with significant nuclear pleomorphism. There was no significant difference in ER tumor heterogeneity between premalignant and malignant lesions.Keywords
This publication has 13 references indexed in Scilit:
- The Value of Imprint Cytology in Cytochemical Detection of Steroid Hormone Receptors in Breast CancerAmerican Journal of Clinical Pathology, 1987
- Risk Factors for Breast Cancer in Women with Proliferative Breast DiseaseNew England Journal of Medicine, 1985
- COMPARISON OF IMMUNOCYTOCHEMICAL AND STEROID-BINDING ASSAYS FOR ESTROGEN-RECEPTOR IN HUMAN-BREAST TUMORS1985
- ESTROGEN-RECEPTOR ANALYSES - CORRELATION OF BIOCHEMICAL AND IMMUNOHISTOCHEMICAL METHODS USING MONOCLONAL ANTIRECEPTOR ANTIBODIES1985
- INFLUENCE OF CELL-PROLIFERATION AND CELL-CYCLE PHASE ON EXPRESSION OF ESTROGEN-RECEPTOR IN MCF-7 BREAST-CANCER CELLS1984
- Monoclonal antibodies as probes for estrogen receptor detection and characterizationThe Journal of Steroid Biochemistry and Molecular Biology, 1982
- RELATIONSHIP OF STEROID-RECEPTOR, CELL-KINETICS, AND CLINICAL STATUS IN PATIENTS WITH BREAST-CANCER1981
- RELATIONSHIPS OF S-PHASE FRACTION OF BREAST-CARCINOMA IN RELAPSE TO DURATION OF REMISSION, ESTROGEN-RECEPTOR CONTENT, THERAPEUTIC RESPONSIVENESS, AND DURATION OF SURVIVAL1980
- Low incidence of estrogen receptor in breast carcinomas with rapid rates of cellular replicationCancer, 1977
- Assessment of response to therapy in advanced breast cancerBritish Journal of Cancer, 1977